Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Apr 28, 2026
Meta Platforms (META): Q1 2026 Earnings Preview – +31% Revenue Growth in Sight

Meta Platforms (META): Q1 2026 Earnings Preview – +31% Revenue Growth in Sight

Key Takeaways

  • Analysts anticipate Q1 2026 revenue of approximately $55.4 billion, reflecting about 31% year-over-year growth and aligning with company guidance of $53.5-56.5 billion.
  • Consensus earnings per share (EPS) stands at $6.67, supported by strong advertising margins despite rising AI-related costs.
  • Key metrics to watch include Family Daily Active People (DAP, the total number of people using Meta's family of apps daily) and average revenue per person (ARPP).
  • Investors are focused on updates to 2026 capital expenditures (capex), projected at $115-135 billion, amid heavy AI infrastructure spending.
  • Meta has a history of beating earnings estimates, with shares averaging a 3.4% gain in the day following recent reports.
  • Guidance for Q2 and full-year 2026 expenses, estimated at $162-169 billion, will shape views on profitability.

Earnings Context and Why It Matters

Meta Platforms (META) is heading into its Q1 2026 earnings report with solid momentum in ad revenue carried over from 2025, when Q4 revenue reached a record $59.89 billion, up 24% year-over-year. As the company behind Facebook, Instagram, and WhatsApp, advertising accounts for over 95% of its revenue. From what I see, this earnings release is particularly important because it will test whether that ad growth can hold steady amid economic headwinds and competition from platforms like TikTok. Investors will be looking for insights into user engagement, the impact of AI-powered ad tools, and progress in Reality Labs, which handles Quest VR headsets and metaverse initiatives. With shares trading near all-time highs following strong 2025 results, the outcome here could sway sentiment around Big Tech's ongoing AI investment push.

Earnings Expectations

Wall Street's consensus calls for Q1 2026 revenue of $55.36 billion to $55.56 billion, representing roughly 31% growth from $42.31 billion in Q1 2025, which fits squarely within META's guidance of $53.5-56.5 billion provided in the Q4 report. EPS estimates sit at $6.67, pointing to ongoing margin expansion driven by efficient ad targeting and cost discipline.

Key metrics in focus include Family DAP, projected at around 3.3-3.4 billion, and advertising revenue close to $54.4 billion. Growth in ARPP will indicate the strength of ad pricing power. META has a track record of surpassing estimates—Q1 2025 EPS beat forecasts by 16%—though forward guidance often dictates the market's response. I'll be paying close attention to updates on AI ad products like Advantage+ and Llama models, which have been enhancing performance, as well as any news from Reality Labs, which posted significant losses last year. I also checked META against industry peers using Tickeron’s AI Screener, and it underscores the company's competitive edge.

Market Reaction and Investor Sentiment

As we head into Q1 earnings on April 29, sentiment around META feels cautiously optimistic, supported by the 2025 ad recovery but checked by escalating AI capex. Options pricing suggests about 8-10% volatility after the report, in line with past moves. Shares have climbed in 8 of the last 12 quarters following earnings, averaging a +3.4% gain, but misses on guidance—such as the Q3 2025 capex increase—have triggered pullbacks. Risks to watch include potential ad spending softness tied to China exposure or broader economic slowdowns, while beats on user growth and margins could drive further gains.

Tools I Use: Tickeron’s AI Screener

In my own analysis, I frequently rely on Tickeron’s AI Screener, an AI-powered stock and ETF discovery tool that lets me filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. It scans thousands of stocks and ETFs with customizable filters like industry, market cap, technical indicators, price patterns, and performance metrics, helping pinpoint trade ideas, trending stocks, breakout candidates, and opportunities far more efficiently than manual methods. One thing that stands out is how it streamlines research—I've found it invaluable for stocks like META.

Forward Outlook and Key Factors to Monitor

After earnings, attention will turn to META's full-year 2026 guidance, with total expenses forecasted at $162-169 billion and capex at $115-135 billion—roughly double 2025 levels—to support AI data centers and models like Llama 4. This spending may weigh on near-term margins but positions the company for long-term gains in ad efficiency.

User trends merit close watching: consistent DAP expansion alongside Threads surpassing 200 million users and ongoing Reels monetization. Advertising stays central, with AI tools poised to improve return on ad spend (ROAS). Reality Labs losses could ease if Quest sales pick up, though metaverse investments continue.

On the bigger picture, regulatory pressures around privacy and antitrust, AI rivalry from OpenAI and Google, and U.S. consumer spending trends will all play roles in ad budgets. I'm watching for catalysts like the F8 developer conference and Q2 ad seasonality. Tickeron’s AI Trend Prediction Engine has been helpful here in gauging potential trajectories.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: META

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Aroon Indicator for META shows an upward move is likely

META's Aroon Indicator triggered a bullish signal on July 24, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 275 similar instances where the Aroon Indicator showed a similar pattern. In of the 275 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where META's RSI Oscillator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where META advanced for three days, in of 324 cases, the price rose further within the following month. The odds of a continued upward trend are .

META may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on July 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on META as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for META turned negative on July 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

META moved below its 50-day moving average on July 24, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for META crossed bearishly below the 50-day moving average on July 31, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where META declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.774) is normal, around the industry mean (5.806). P/E Ratio (22.301) is within average values for comparable stocks, (29.512). Projected Growth (PEG Ratio) (0.884) is also within normal values, averaging (32.401). Dividend Yield (0.004) settles around the average of (0.043) among similar stocks. P/S Ratio (6.658) is also within normal values, averaging (70.694).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. META’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Alphabet (NASDAQ:GOOG), Alphabet (NASDAQ:GOOGL), Meta Platforms (NASDAQ:META), Spotify Technology SA (NYSE:SPOT), Nebius Group N.V. (NASDAQ:NBIS), Baidu (NASDAQ:BIDU), Tencent Music Entertainment Group (NYSE:TME), Pinterest (NYSE:PINS), Snap (NYSE:SNAP), Bilibili (NASDAQ:BILI).

Industry description

Companies in this industry typically license software on a subscription basis and it is centrally hosted. Such products usually go by the names web-based software, on-demand software and hosted software. Cloud computing has emerged as a major force in this space, making it possible to save files to a remote database (without requiring them to be saved on local storage device); as long as a device has access to the web, it can access the data and the software programs to run it. This has in many cases facilitated cost efficiency, speed and security of data for businesses and consumers. Alphabet Inc., Facebook, Inc. and Yahoo! Inc. are some well-known names in the internet software/services industry.

Market Cap

The average market capitalization across the Internet Software/Services Industry is 145.87B. The market cap for tickers in the group ranges from 2.69K to 4.33T. GOOGL holds the highest valuation in this group at 4.33T. The lowest valued company is STBXF at 2.69K.

High and low price notable news

The average weekly price growth across all stocks in the Internet Software/Services Industry was 34%. For the same Industry, the average monthly price growth was 14%, and the average quarterly price growth was 5%. NAMI experienced the highest price growth at 60%, while ONFO experienced the biggest fall at -46%.

Volume

The average weekly volume growth across all stocks in the Internet Software/Services Industry was -25%. For the same stocks of the Industry, the average monthly volume growth was 1% and the average quarterly volume growth was -51%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 72
Price Growth Rating: 59
SMR Rating: 79
Profit Risk Rating: 94
Seasonality Score: -1 (-100 ... +100)
View a ticker or compare two or three
META
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a social networking service and website

Industry InternetSoftwareServices

Profile
Details
Industry
Internet Software Or Services
Address
1 Meta Way
Phone
+1 650 543-4800
Employees
78865
Web
https://about.meta.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.